Noronha IH, Wada LN, Rossetto BS, Moraschi BF, Ferreira CP, Santos Santana JK, do Valle RD, Júnior LCGP, Aristeu da Rosa J, Rosa DS, Kim Y, Lopes MF, Ribeiro DA, Gazzinelli RT, Bortoluci KR, Trossini GHG, Silveira ELV, de Vasconcelos JRC. Intranasal Vaccination With Recombinant Human Adenovirus Encoding trans-Sialidase Gene Protects Mice From Lethal Subcutaneous and Oral Trypanosoma cruzi Challenges. J Infect Dis. 2026 Sep 23; 234(3):449-461.

Moreira-Nascimento SL, Nascimento MFA, Fernandes GM, Afonso SL, Gunderman VHG, Rodrigues BA, Lopes SCP, Fabbri C, Lacerda MVG, Almeida GG, Longley RJ, Mueller I, Antonelli LRDV, Ntumngia FB, Adams JH, Teixeira-Carvalho A, Carvalho LH, Kano FS. Cytokine signatures associated with persistent antibody responses to multiple Plasmodium vivax blood-stage antigens. Front Immunol. 2026; 17:1899417.

Sampaio JR, Coelho FF, Soares IDS, Oliveira JKA, Gazzinelli-Guimarães AC, Carvalho AF, Valiate BVS, Costa CM, Junqueira C, Silva AMV, Oliveira-Silva M, Pereira DB, de Pina-Costa A, Siqueira AM, Castro MC, Souza RP, Antonelli LRDV, Fernandes APSM, Gazzinelli RT, Almeida GG. A rapid immunochromatographic test for antibody detection as a new tool for monitoring malaria caused by Plasmodium vivax. PLoS Negl Trop Dis. 2026 Jun; 20(6):e0014447.

Cummings BE, Stucke EM, Coulibaly D, Lawton JG, Sobota RS, Kone AK, Kane B, Guindo B, Tangara B, Sissoko M, Maiga F, Traore K, Diawara A, Traore A, Thera A, Dara A, Niangaly A, Daou M, Diarra I, Tolo Y, Sebastian S, Jain A, Nakajima R, Jasinskas A, Silzel EK, Shrestha B, Ouattara A, Munro JB, Laurens MB, Lyke KE, Tebben K, Bogale H, Plowe CV, Sissoko MS, Kouriba B, Takala-Harrison S, Felgner PL, Silva JC, Doumbo OK, Thera MA, Travassos MA. Plasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes. J Infect. 2025 Dec; 91(6):106655.

Dos Santos NSA, de Almeida-Júnior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.

Gómez-Pérez GP, Vidal M, Campo JJ, Moncunill G, Jimenez A, Vázquez-Santiago M, Ruiz-Olalla G, Sanz H, Ayestaran A, Angov E, Dutta S, Chitnis C, Chauhan V, James ER, Billingsley PF, Sim BKL, Kremsner PG, Hoffman SL, Lell B, Mordmüller B, Dobaño C. IgM, IgG, and IgG Subclass Antibody Responses to Plasmodium falciparum Proteins in Naïve, Malaria-Vaccinated and Semi-Immune Volunteers after Controlled Human Malaria Infection. Am J Trop Med Hyg. 2025 Dec 03; 113(6):1235-1248.

Forconi CS, Nixon C, Wu HW, Odwar B, Pond-Tor S, Ong'echa JM, Kurtis JD, Moormann AM. T-follicular helper cell profiles differ by malaria antigen and for children compared to adults. Elife. 2025 May 22; 13.

de Oliveira B, Goes WM, Nascimento FC, Carnielli JBT, Ferreira ER, de Carvalho AF, Dos Reis PVM, Pereira M, Ricotta TQN, Dos Santos LM, de Souza RP, Cargnelutti DE, Mottram JC, Teixeira SR, Fernandes AP, Gazzinelli RT. Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine. mSphere. 2025 May 27; 10(5):e0009725.

Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares IS. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine. 2024 04 02; 42(9):2394-2406.

Jongo S, Church LWP, Milando F, Qassim M, Schindler T, Rashid M, Tumbo A, Nyaulingo G, Bakari BM, Athuman Mbaga T, Mohamed L, Kassimu K, Simon BS, Mpina M, Zaidi I, Duffy PE, Swanson PA, Seder R, Herman JD, Mendu M, Zur Y, Alter G, Kc N, Riyahi P, Abebe Y, Murshedkar T, James ER, Billingsley PF, Sim BKL, Richie TL, Daubenberger C, Abdulla S, Hoffman SL. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults. J Clin Invest. 2024 Jan 09; 134(6).